0 Комментарии
0 Поделились
2Кб Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Войдите, чтобы отмечать, делиться и комментировать!
-
VEGF-B Inhibitors Market Gains Traction with Advances in Cardiovascular and Oncology Research"Executive Summary VEGF-B Inhibitors Market Size, Share, and Competitive Landscape CAGR Value Global VEGF-B inhibitors market size was valued at USD 1.27 Billion in 2024 and is projected to reach USD 3.75 billion by 2032, with a CAGR of 14.4% during the forecast period of 2025 to 2032. An exceptional VEGF-B Inhibitors Market research document can be formulated well with the blend of top...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Carfilzomib Market Expands with 7.5% CAGR Driven by Advances in Multiple Myeloma TherapiesAccording to a new report from Intel Market Research, the global Carfilzomib market was valued at USD 1.45 billion in 2025 and is projected to reach USD 2.89 billion by 2034, growing at a steady CAGR of 7.5% during the forecast period (2025–2034). This growth reflects the expanding clinical application of Carfilzomib in treating relapsed/refractory multiple myeloma, coupled with rising...0 Комментарии 0 Поделились 352 Просмотры 0 предпросмотр
-
Clinical Oncology Next Generation Sequencing Market Market Size, Top Industry Players and Forecast to 2033Clinical Oncology Next Generation Sequencing Industry Outlook: Straits Research has added a report titled “Global Clinical Oncology Next Generation Sequencing Market Professional Report 2025-2033” to its database of research reports. The study provides complete details about the usage and adoption of Clinical Oncology Next Generation Sequencing in various industrial applications...0 Комментарии 0 Поделились 638 Просмотры 0 предпросмотр
-
Emerging Trends Influencing the Antibody Drug Conjugates MarketAsia-Pacific is expected to witness rapid growth in the coming years due to increasing healthcare investments and expanding pharmaceutical manufacturing capabilities. Countries like China and India are emerging as important research hubs. The Antibody Drug Conjugates (ADC) market is projected to grow significantly, reaching US$38,077.45 million by 2031 from US$8,105.65 million in 2023,...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Future Market Potential of Chemotherapy-Induced Peripheral Neuropathy TreatmentsThe global chemotherapy-induced peripheral neuropathy market size is projected to grow from US$ 1.01 billion in 2025 to approximately US$ 1.67 billion by 2034, reflecting a steady expansion. The market is anticipated to register a compound annual growth rate (CAGR) of around 5.71% during the forecast period, highlighting increasing investments in oncology supportive care. The...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Global CAR-T Cell Therapy Market Growth at 17.5% CAGR Through 2030Increasing research and development activities in cell-based therapies are supporting the expansion of the CAR-T cell therapy market. Pharmaceutical and biotechnology companies are investing heavily in clinical trials and advanced technologies. These efforts are accelerating the development of new and effective cancer treatments. CAR-T Cell Therapy Market to Reach US$ 10.13 Billion by 2030...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
How Cancer Treatment Demand Is Expanding the Asia-Pacific Taxane MarketExecutive Summary Asia-Pacific Taxane Market Size and Share: Global Industry Snapshot CAGR Value Asia-Pacific taxane market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 8.7% in the forecast period of 2022 to 2029. The research and analysis carried out in this Asia-Pacific...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
How the Prostate Cancer Diagnostics Market Is Advancing with AI and Biomarker-Based Screening?Executive Summary Prostate Cancer Diagnostics Market: Growth Trends and Share Breakdown CAGR Value The global prostate cancer diagnostics market size was valued at USD 4.63 billion in 2024 and is expected to reach USD 10.31 billion by 2032, at a CAGR of 10.50% during the forecast period Prostate Cancer Diagnostics Market research report is a verified source of data and information that...0 Комментарии 0 Поделились 5Кб Просмотры 0 предпросмотр
-
Immunotherapy Impact on the Anti-cancer Drugs MarketThe rapid growth of the biotechnology sector is supporting breakthroughs in anti-cancer drug development. Researchers are leveraging advanced technologies such as gene therapy and cell-based therapies. These innovations are opening new possibilities in cancer treatment. The Anti-cancer Drugs Market is anticipated to expand at a CAGR of 9.2% from 2026 to 2034, reflecting steady innovation and...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
VEGF Inhibitors for Cancer Market Growing at 7.3% CAGR Amid Rising Targeted Oncology TherapiesAccording to a new report from Intel Market Research, the global VEGF Inhibitors for Cancer market was valued at USD 8.42 billion in 2025 and is projected to reach USD 15.67 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2026–2034). This growth trajectory reflects the increasing adoption of targeted therapies in oncology and significant advancements in angiogenesis...0 Комментарии 0 Поделились 447 Просмотры 0 предпросмотр
-
Why Oncology Advancements Are Supporting the Europe Taxane MarketExecutive Summary Europe Taxane Market Size and Share Forecast CAGR Value Europe taxane market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 7.1% in the forecast period of 2022 to 2029. The Europe Taxane report also makes available CAGR value fluctuation during the forecast...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
Расширенные страницы